GRGD.TO(GRGD.TO)
GRGD.TO
No analyst ratings available
No analyst price targets available for GRGD.TO
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E |
|---|---|---|---|
| Revenue Avg | $1.61B | $1.84B | $2.10B |
| Low | $1.59B | $1.80B | $2.10B |
| High | $1.63B | $1.89B | $2.10B |
| EBITDA Avg | $494M | $563M | $644M |
| Low | $486M | $553M | $644M |
| High | $500M | $579M | $644M |
| EBIT Avg | $356M | $406M | $464M |
| Low | $351M | $399M | $464M |
| High | $361M | $418M | $464M |
| Net Income Avg | $348M | $414M | $481M |
| Low | $343M | $405M | $469M |
| High | $361M | $424M | $493M |
| EPS Avg | $3.08 | $3.61 | $4.19 |
| Low | $3.00 | $3.54 | $4.10 |
| High | $3.15 | $3.70 | $4.31 |
| Analysts (Rev / EPS) | 11 / 6 | 11 / 7 | 5 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $399M | $434M | $472M | $348M | $454M | $493M | $531M | $451M |
| Low | $386M | $427M | $461M | $340M | $443M | $482M | $519M | $441M |
| High | $406M | $440M | $479M | $354M | $461M | $501M | $540M | $459M |
| EBITDA Avg | $122M | $133M | $144M | $107M | $139M | $151M | $163M | $138M |
| Low | $118M | $131M | $141M | $104M | $136M | $148M | $159M | $135M |
| High | $124M | $135M | $147M | $108M | $141M | $154M | $165M | $140M |
| EBIT Avg | $88M | $96M | $104M | $77M | $100M | $109M | $117M | $100M |
| Low | $85M | $94M | $102M | $75M | $98M | $106M | $115M | $97M |
| High | $90M | $97M | $106M | $78M | $102M | $111M | $119M | $101M |
| Net Income Avg | $90M | $104M | $101M | $66M | $106M | $121M | $120M | $79M |
| Low | $87M | $100M | $98M | $64M | $103M | $118M | $116M | $76M |
| High | $93M | $109M | $104M | $67M | $108M | $124M | $122M | $81M |
| EPS Avg | $0.79 | $0.91 | $0.89 | $0.58 | $0.93 | $1.06 | $1.05 | $0.69 |
| Low | $0.76 | $0.87 | $0.86 | $0.56 | $0.90 | $1.03 | $1.02 | $0.67 |
| High | $0.81 | $0.95 | $0.91 | $0.59 | $0.94 | $1.08 | $1.07 | $0.70 |
| Analysts (Rev / EPS) | 9 / 11 | 8 / 10 | 4 / 4 | 6 / 4 | 4 / 4 | 6 / 4 | 3 / 5 | 5 / 5 |